Literature DB >> 6193333

Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.

F Ramaekers, A Huysmans, O Moesker, A Kant, P Jap, C Herman, P Vooijs.   

Abstract

A monoclonal antibody (RGE 53) against keratin intermediate filaments was prepared by fusing myeloma cells with splenic lymphocytes from mice immunized with a HeLa cell cytoskeleton preparation and human callus keratins. The antibody, selected for fibrillar staining in HeLa cells and a negative reaction on human skin, was tested on frozen sections from normal and malignant human tissues. RGE 53 specifically recognizes glandular epithelial cells from female breast, digestive, respiratory, and urogenital tracts, endocrine and exocrine tissues, and mesothelial cells. No reaction is found in stratified squamous epithelia or nonepithelial tissues. Furthermore, RGE 53 can distinguish adenocarcinomas and mesotheliomas, which stain positively in the indirect immunofluorescence technique from squamous cell carcinomas and nonepithelial tumors, which are negative for this antibody. RGE 53 may, therefore, be a useful tool for differential diagnosis in surgical pathology, especially in those cases in which anaplastic carcinomas have to be characterized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193333

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  69 in total

1.  An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions.

Authors:  W Böcker; B Bier; G Freytag; B Brömmelkamp; E D Jarasch; G Edel; B Dockhorn-Dworniczak; K W Schmid
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Distribution of epithelial antigens in the human uterine cervix: a review.

Authors:  V Serra; A Ramirez; M C Marzo; F Valcuende; C Lara; A Castells; F Bonilla-Musoles
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Tissue culture of epithelial cells from esophageal specialized columnar epithelium (Barrett's esophagus).

Authors:  H S Garewal; A Leibovitz; R E Sampliner; L Ramsey; M J Hendrix; D Sloan
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  Expression of cytokeratin polypeptides during development of the rat inner ear.

Authors:  W Kuijpers; T A Peters; E L Tonnaer; F C Ramaekers
Journal:  Histochemistry       Date:  1991

Review 5.  Intermediate filaments: a historical perspective.

Authors:  Robert G Oshima
Journal:  Exp Cell Res       Date:  2007-04-11       Impact factor: 3.905

6.  Cytokeratin polypeptides expression in different epithelial elements of human salivary glands.

Authors:  S Geiger; B Geiger; O Leitner; G Marshak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

7.  Immunolocalisation of cytokeratins in the normal and neoplastic human pituitary gland.

Authors:  J W Ironside; J A Royds; A A Jefferson; W R Timperley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

8.  Intermediate filament protein expression in early developmental stages of the mouse. A confocal scanning laser microscopy study of in vitro fertilized and in vitro cultured pre-implantation mouse embryos.

Authors:  E Coonen; J C Dumoulin; F C Ramaekers
Journal:  Histochemistry       Date:  1993-02

9.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

10.  Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study.

Authors:  P M Steijlen; D O Reifenschweiler; F C Ramaekers; G N van Muijen; R Happle; M Link; D J Ruiter; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.